Sarah Cannon Lung Cancer Research Program

Sarah Cannon is leading cutting-edge research to find new therapies for lung cancer, the deadliest form of cancer in the U.S., and providing patients access to innovative treatments in their communities. Dr. David Spigel, Director of Sarah Cannon Lung Cancer Research Program, discusses exciting new developments in lung cancer care such immunotherapy, a way to awaken a patient's own immune system to fight cancer.